HIGHLIGHTS
- who: Ximena Baez-Navarro from the Department of Pathology, Erasmus MC, Rotterdam, the Netherlands Research UK Edinburgh Centre, Institute of Genetics and, The University of Edinburgh, Edinburgh, UK have published the Article: Selecting patients with HER2-low breast cancer: Getting out of the tangle, in the Journal: (JOURNAL) of 15/07/2022
- what: The DB-06 study, focused on comparing the use of T-DXd versus investigator`s choice chemotherapy in HER2-low hormone_receptor positive metastatic BC, is ongoing . The authors propose to the scientific community, industry as well as the regulatory authorities a set . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.